Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Non-antibiotic drugs

PROVIDER: PRJNA1008034 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25743113_1.fastq.gz	Fastqsanger.gz
	SRR25743113_2.fastq.gz	Fastqsanger.gz
	SRR25743114_1.fastq.gz	Fastqsanger.gz
	SRR25743114_2.fastq.gz	Fastqsanger.gz
	SRR25743115_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

aquatic metagenome

Project description:Non-antibiotic drugs and antibiotic resistance in river water

| PRJDB20794 | ENA

Non-antibiotic drugs break colonization resistance against pathogenic Gammaproteobacteria

Project description:Non-antibiotic drugs break colonization resistance against pathogens

| PRJEB65315 | ENA

Project description:Non-antibiotic drugs promote transfer of E.coli RP4.

| PRJNA962005 | ENA

Common non-antibiotic drugs enhance selection for antimicrobial resistance in mixture with ciprofloxacin

Project description:Non-antibiotic drugs enhance AMR in mixture with ciprofloxacin

| PRJEB88784 | ENA

Project description:Lab evolution of E. coli to three non antibiotic drugs

| PRJNA998361 | ENA

Agilent_E. coli O157 response to Chrysanthemum herba

Project description:According to our study, Chrysanthemum lavandulifolum extract showed excellent antibiotic effects on Escherichia coli O157:H7. A notable point is that the antibiotic efficacy of the herb extract is on the all three proven targets for main antibiotic drugs that are bacterial cell wall biosynthesis, bacterial protein synthesis and bacterial DNA replication and repair. This multi-target efficacy of the herbal antibiotics may be used as more effective and safe drugs that substitute existing antibiotics.

2010-12-14 | GSE26017 | GEO

Region-specific effects of drugs on the gut ecosystem

Project description:To advance our understanding of the regional molecular effects of non-antibiotic drugs on the gut ecosystem, we performed multi-omics analysis of different mice intestinal regions after oral administration of 33 commonly used drugs (n=8, one drug for each animal, (n=10 for the control group)),

2025-08-12 | PXD067247 |

null

Project description:Antimicrobial effects, and selection for AMR by non-antibiotic drugs on bacterial communities

| PRJEB74464 | ENA

Stokes2020 - Antibiotics discovery using deep learning approach.

Project description:Based on a simple E.coli growth inhibition assay, the authors trained a model capable of identifying antibiotic potential in compounds structurally divergent from conventional antibiotic drugs. One of the predicted active molecules, Halicin (SU3327), was experimentally validated in vitro and in vivo. Model Type: Predictive machine learning model. Model Relevance: Probability that a compound inhibits E.coli growth. Model Encoded by: Miquel Duran-Frigola(Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos4e40

2024-04-22 | MODEL2404080001 | BioModels

RNA Sequencing of macrophages harboring redox-diverse Mycobacterium tuberculosis.

Project description:The ability of Mycobacterium tuberculosis (Mtb) to tolerate antibiotics is a major impediment in the treatment of tuberculosis. This antibiotic tolerance is influenced by the host cells in which the bacteria reside, as Mtb senses host cues, and the bacterial response can provide an enhanced ability to withstand anti-TB drugs. Previouslyt, we have shown that Mtb exhibits redox heterogeneity in terms of its mycothiol redox potential (EMSH) giving rise to three broad subpopulations EMSH-reduced, EMSH-basal, and EMSH-oxidized Mtb specifically inside the macrophages. Among these, the EMSH-reduced Mtb exhibit enahnced tolerance to several anti-TB drugs while the EMSH-basal and EMSH-oxidized subpopulations are more susceptible. In this study, we explored the transcriptomic level differences between macrophages that harbor the antibiotic tolerant Mtb and those harboring antibiotic susceptible Mtb to get a mechanistic understanding of host factors that influence drug tolerance in intracellular Mtb.

2025-08-14 | GSE283664 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data